Experts in: Cohort studies
BLASER, Christine
Professeure adjointe de clinique
- Epidemiology
- Surveillance
- Social epidemiology
- Population’s health
- Social Determinants of Health
- Social inequality
- Vulnerability
- Social determinants
- COVID-19
- Longitudinal studies
- Vaccination
- Demography
- Skills development in public health
- Public health
- Social Networks
- Communication for health
- Surveys
- Databases
- Multivariate analysis
- Cohort studies
- Case studies
- Multilevel analysis
- Deprived neighbourhoods
- Living environment
- Ethnocultural communities
- Socioeconomic status
- Interethnic relationships
- Immigrants
- Sociological theories
- Immigration
- Ethnic attitudes
- Cultural diversity
DUCHARME, Francine M.
Professeure titulaire
- Respiratory System
- Asthma
- Child
- Life Cycles ( Childhood, Adolescence, Adulthood, etc.)
- Patient compliance
- Teenager
- Youths
- Epidemiology
- Respiratory Tract Diseases
- Healthcare/Healthcare quality evaluation
- Clinical medicine
- Qualitative methods
- Quantitative methods
- Mixed methods
- Pharmacoepidemiology
- Decision making
- Quality of health care
- Evaluative research
- Operations research
- Randomized clinical trial
- Meta-Analysis
- Cohort studies
- COVID-19
O'LOUGHLIN, Jennifer
Professeure titulaire
- Youths
- Teenager
- Epidemiology
- Longitudinal studies
- Méthodes de recherche
- Quantitative methods
- Prevention
- Public health
- Smoking
- Child
- Exercise
- Obesity
- Cohort studies
Dr. O’Loughlin is a Professor in the School of Public Health at the University of Montreal. She is a senior member of the Health Innovation and Evaluation Hub in the University of Montreal Hospital Research Center (CRCHUM), a fellow of the Canadian Academy of Health Sciences, a consultant to the Tobacco Control Research team at the Institut national de sante publique (INSPQ) and an elected member of the American Academy of Pediatrics Tobacco Consortium. Her team is housed at the CRCHUM and in addition to local researchers Dr. O’Loughlin has many ongoing collaborations nationally and internationally. During her 10-year tenure (to date) as a Tier I Canada Research Chair in the Early Determinants of Adult Chronic Disease, her research had focused on increased understanding of the relative importance of genetic, psychosocial, behavioral and environmental determinants of the childhood risk for adult chronic disease. She heads two pediatric cohort investigations (i.e., the Nicotine Dependence in Teens (NDIT) Study and AdoQuest) and she is a co-investigator on another four.
From 2007-13, she headed an interdisciplinary capacity enhancement team (funded 1.5 million by the CIHR), which included 35 investigators and students working on tobacco control research. Her research output over the past 5 years includes 123 publications and over 151 presentations at local, national and international conferences, as well as Knowledge Transfer products including 13 “Feuillets” on her work with INSPQ practitioners improving cessation counseling practices in six health professional groups. These feuillets are distributed to tobacco control practitioners and policy makers across Quebec and help assure that the results of her research are incorporated in practice.
Dr. O’Loughlin’s work has attracted media coverage, and she was one of the University of Montreal’s Top Newsmakers in 2008. Perhaps a key indicator of how her work is influential, is its citation in “Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General, 2012” and “A Report of the Surgeon General: How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease, 2010.” Her research is also cited in a recent INSPQ submission to the Quebec government on proposed legislative changes to the Quebec Tobacco Control Act. Overall Dr. O’Loughlin’s work exemplifies interdisciplinary research that is well-grounded in public health, it demonstrates leadership in child and adolescent research, and it provides the “cells to society” underpinnings for furthering early prevention of adult chronic disease.
VERNER, Marc-André
Professeur agrégé
- Toxicology
- Exposure modelling
- Physiologically based pharmacokinetic (PBPK)
- Toxicokinetic models
- Toxicokinetics
- Exposure measurement
- Predictive toxicology
- Biological monitoring/Biomotoring
- Toxicological risk analysis
- Risk assessment
- Environmental epidemiology
- Women’s/Maternal health/Maternity
- Environmental Health
- Toxic substance
- Chemical contaminants
- Polychlorinated biphenyls (PCB)
- Persistent organic pollutant
- Perfluoroalkyl Compounds
- Flame retardants
- Cohort studies
- Longitudinal studies
- Occupational exposure assessment
- Pesticides
- Child
- Environment
- Metals in the environment
- Environmental toxicology
- Pharmaceutical pollution
ZINSZER, Kate
Professeure agrégée
- Epidemiology
- Global health
- Population health intervention assessment
- Public health
- Surveillance
- Quantitative methods
- Méthodes de recherche
- Climatic changes
- Environmental epidemiology
- Information systems
- Field Epidemiology (outbreak management)
- Randomized clinical trial
- Medical geography
- Public health practice
- Cohort studies
- Longitudinal studies
- Evaluation studies
- COVID-19
- COVID19
- Canada
- Sub-Saharan Africa
- South America
My interdisciplinary training allows me to use tools from epidemiology, public health, informatics, and statistics to untangle the causes, forecast future burdens, and evaluate intervention effectiveness of vector-borne diseases. I am also interested in climate change implications for vectorborne diseases. Specifically, my research is focused on malaria, arboviruses (dengue, chikungunya, Zika), and most recently, Lyme disease.
1. Evaluation of large-scale vector-borne disease interventions
I have been involved with evaluating the effectiveness of large-scale malaria interventions and programs including indoor residual spraying and universal bednet coverage in Uganda. I have recently begun to evaluate a community mobilization approach for arbovirus control in Fortaleza, Brazil with various partners.
2. Infectious disease forecasting and spatiotemporal modelling
I am interested in applying different forecasting methods and data streams for disease burden estimations, and most recently exploring machine learning methods. I also use spatiotemporal methods to understand the patterns of disease emergence, identifying at-risk locations and time periods, and disease determinants.
3. Estimating the impact of climate change on vector-borne diseases (VBD)
Climate change will have important implications for future VBD and using different scenarios, we forecast future disease burdens using various methods. We also consider sociodemographic changes and intervention scenarios in our work.
4. Improving disease surveillance
I am involved with various malaria surveillance projects which aim to integrate fragmented data sources and improve data harmonization. Most recently, we are evaluating the biases in reported arboviral cases in the national surveillance system in Colombia.